Joshua Schiffman

Dr. Joshua Schiffman is a pediatric hematologist-oncologist at Primary Children's Hospital (PCH) and Huntsman Cancer Institute (HCI) at the University of Utah.  He attended the Brown University School of Medicine, followed by pediatric residency and chief residency at Stanford University School of Medicine.  He completed his fellowship training in Pediatric Hematology-Oncology at Stanford University.  While at Stanford, he began their Pediatric Cancer Genetics Program.  Dr. Schiffman has been on the faculty at the University of Utah since 2008, where he is Professor in Pediatrics and an Adjunct Professor in Oncological Sciences.  He serves as the Medical Director for the High Risk Pediatric Cancer Clinic at the University of Utah, where he cares for children and families with inherited risk for cancer.  Dr. Schiffman also is the Education Director for the Program in Personalized Health, where he oversees the teaching of translational and individualized clinical medicine to physicians and their patients.  Dr. Schiffman's research focuses on the development of pediatric cancer and he runs a translational genomics laboratory to identify which children are at risk for cancer and why.  Dr. Schiffman works closely with epidemiologists, population scientists, and molecular biologists to try to answer this question.  Most recently, Dr. Schiffman has recognized the power of comparative oncology to advance the field of cancer research.  Teaming up with collaborators from across the country, the Schiffman Lab is now actively involved in comparing the genomics and functional biology of different species across the animal kingdom and using this information to generate hypotheses and guide experimental design in cancer research.  Dr. Schiffman holds the inaugural Edward B. Clark, MD Endowed Chair in Pediatric Research.